Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human LECT2 ELISA Kit (AC3103)
Cat.#: ASET-1692
Specifications
Description Human LECT2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human LECT2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.26 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 7.5-120 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1222 Human PDE7B ELISA Kit (AC2633) Quantitative inquiry ASET-2409 Mouse Ornithine Aminotransferase ELISA Kit (AC3820) Quantitative inquiry ASET-2543 Human Neuropilin 1 ELISA Kit (AC3954) Quantitative inquiry ASET-1530 Human Neuritin ELISA Kit (AC2941) Quantitative inquiry ASET-2025 Human HNT ELISA Kit (AC3436) Quantitative inquiry ASET-2164 Rat GDF6 ELISA Kit (AC3575) Quantitative inquiry ASET-2249 Mouse Pcsk1n ELISA Kit (AC3660) Quantitative inquiry ASET-2520 Rat MMP24 ELISA Kit (AC3931) Quantitative inquiry ASET-1426 Sheep Luteinizing Hormone ELISA Kit (AC2837) Quantitative inquiry ASET-1184 Rat Somatostatin ELISA Kit (AC2595) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket